In partnership with
Stock: VitalHub (TSX: VHI)
VitalHub (TSX: VHI) is a Canadian healthcare technology company that provides software for hospitals, regional health authorities, mental health, long-term care, community care, and social services. Its solutions cover areas like electronic health records, patient flow, care coordination, operational visibility, and case management.
These Founders Unlocked 22X Growth
In 2018, Brandon and Jennifer Robinson licensed a single mini-golf pub. They had a hunch people wanted more than just a bar. They wanted an experience.
Five locations later, Tipsy Putt is boasting 5,188 active members and 22x revenue growth.
Over 10,000 people have downloaded Tipsy Putt’s app. The company has been featured on the Dan Patrick Show, and celebrity guests keep walking through the doors.
This is a proven, operating brand with a loyal fanbase and momentum that keeps compounding.
Now the Robinsons are opening their San Francisco flagship, and retail investors can own shares in the location before the 2027 grand opening.
This is a paid advertisement for Tipsy Putt Regulation CF offering. Please read the offering circular at https://invest.tipsyputt.com/
Quick Take: VitalHub is a high-growth Canadian healthcare software stock with strong analyst support, a clean balance sheet, and meaningful upside potential. The stock is still down from its 52-week high, but analysts see room for a major recovery, with an average target price implying 56.6% upside.
Major Developments This Week & Near-Term
Market performance: Shares rose 3.2% over the last 5 days, outperforming the broader healthcare information services group.
Strong monthly bounce: The stock is up 19.4% over the last month, suggesting investor sentiment has started to recover.
Still below highs: VitalHub trades at only 56.7% of its 52-week high, leaving room for a rebound if growth continues.
Undervaluation attention: A recent Simply Wall St / Yahoo Finance screen listed VitalHub among TSX stocks trading well below estimated intrinsic value, showing it at CA$8.14 vs estimated fair value of CA$15.56, or about 47.7% undervalued.
Next earnings date: The next quarterly report is expected on May 14, 2026.
Key Metrics (as of Monday’s close)
Metric | Value |
|---|---|
Stock Price | $8.30 |
Weekly Move (5-day) | +3.2% |
Market Cap | US$384M |
P/E Ratio | 83.3 |
Forward P/E | 23.4 |
52-Week Range | $6.67 – $14.64 |
YTD Return | -12.4% |
Dividend Yield | N/A |
Advertise with Wealth Awesome
Want to get in front of our audience of 20,000+ savvy Canadians ?
Analyst Insights
Item | Detail |
|---|---|
Consensus Rating | STRONG BUY ⭐⭐⭐⭐⭐ |
Average Target Price | $13.00 |
Upside Potential | +56.63% |
Analyst Breakdown | Strong Buy: 7 • Buy: 3 • Hold: 0 • Sell: 0 • Strong Sell: 0 |
Read: Analysts are highly bullish on VitalHub. The full analyst group is split only between Strong Buy and Buy, with no Hold or Sell ratings. That is a strong signal that the Street still sees the recent weakness as a potential buying opportunity.
Recent / Notable News
Undervalued TSX screen: VitalHub was highlighted in a recent Yahoo Finance / Simply Wall St article as one of Canada’s undervalued stocks based on cash flow estimates, trading at a large discount to estimated fair value.
Growth story remains intact: The company’s 3-year sales growth average is 36.1%, while its 5-year sales growth average is 46.1%.
Balance sheet strength: VitalHub has no debt, a current ratio of 2.4, and net cash per share of $1.93, which is a major positive for a small-cap growth stock.
Growth Indicators
Metric | VitalHub |
|---|---|
Sales Growth Next Year | +9.2% |
EPS Growth Next Year | +34.0% |
5-Year EPS Growth Estimate | +44.8% |
Sales 1-Year Change | +45.3% |
Sales 5-Year Average | +46.1% |
Growth is the main reason investors watch VitalHub. Sales have expanded strongly over multiple years, and analysts expect EPS to grow sharply next year.
Profitability & Financials
Gross margin: 80.4%
Operating margin: 11.2%
Net margin: 5.6%
Debt/Equity: 0.0
Interest coverage: 84.9
Net cash per share: $1.93
VitalHub’s strongest financial feature is its balance sheet. The company has no debt, strong liquidity, and very high gross margins, giving it flexibility to keep investing in growth.
Technical & Momentum
Technical Metric | Value |
|---|---|
RSI | 64.7 |
Money Flow Index | 67 |
Price vs 52-week high | 56.7% |
Price vs 52-week low | 124.4% |
Price vs 50-day average | 107.8% |
Beta 1-year | 0.85 |
Momentum has improved recently, but the stock remains far below its prior high. That makes VitalHub interesting for investors looking for a rebound candidate rather than a stock already priced for perfection.
What to Watch Next
May 14 earnings: Watch revenue growth, margin expansion, and recurring revenue trends.
Analyst target support: The $13 average target implies major upside if execution stays strong.
Healthcare software demand: Hospitals and health systems continue investing in digitization and patient-flow tools.
Valuation discipline: The stock is cheaper than its highs, but still trades at a high trailing P/E, so growth needs to continue.
Gladly Connect Live '26. May 4–6 in Atlanta.
The room you want to be in. This is where CX leaders are tackling the hard AI questions and sharing what's actually working. For CX and ecommerce leaders. Atlanta, May 4–6. Space is limited — secure your spot now.
One-Look Summary
Aspect | Snapshot |
|---|---|
Thesis | High-growth Canadian healthcare software stock with strong analyst support |
Catalysts | May earnings, healthcare digitization, potential valuation recovery |
Risks | High trailing valuation, small-cap volatility, EPS estimate cuts |
Who it’s for | Growth investors comfortable with small-cap healthcare tech |
Advertise with Wealth Awesome
Want to get in front of our audience of 20,000+ savvy Canadians ?
Bottom Line
VitalHub (TSX: VHI) looks like one of the more interesting TSX growth stocks heading into 2026. The company has strong sales growth, a debt-free balance sheet, high gross margins, and a Strong Buy analyst rating.
The stock is still far below its 52-week high, but that is exactly what makes the setup compelling. If VitalHub can keep growing revenue and convert more of that growth into earnings, the stock could have meaningful recovery potential.
The Wealth Awesome Team